Coronavirus channel feed – Endpoints News

Coronavirus channel feed

NIH offers to share Covid-19 technologies with WHO — report

4 years ago

WHO OKs molnupiravir as treatment for Covid-19, after new data from India

4 years ago

FDA begins court-mandated release of thousands of pages on Pfizer's Covid-19 vaccine review

4 years ago

Updated: Weaker Omicron variant is great news for the world, but bad news for Covid-related clinical trials

4 years ago

Biden continues his pledge for Medicare drug price negotiations in State of the Union speech

4 years ago

How Operation Warp Speed clashed with Pfizer in the early days of the pandemic

4 years ago

EMA shortens timeline for Moderna's Spikevax Covid booster

4 years ago

Covid-19 roundup: Valneva runs into EMA questions, still expects March authorization; Canada approves first plant-based vaccine

4 years ago

Japan, UK pledge new funds to CEPI's $3.5B pandemic preparedness plan, with eye toward future outbreaks

4 years ago

AstraZeneca's Evusheld and GSK's sotrovimab lose efficacy against Omicron's subvariants

4 years ago

mRNA for all: WHO establishes biomanufacturing training hub in Korea

4 years ago

Sanofi, GSK prep regulatory filings for Covid-19 vaccine after posting PhIII, booster data — but who will use it?

4 years ago

Covid-19 roundup: Africa CDC to seek vaccine donation pause — report; New study suggests blood clots from AstraZeneca shot are very rare

4 years ago

FDA slams former CytoDyn CEO's misleading interview in new warning letter

4 years ago

After raising more than $750M in quick Covid cash, Tillman Gerngross is on his way out of troubled Adagio

4 years ago

Public Citizen accuses Pfizer of building 'patent wall' for Covid treatment, setting up inequities again

4 years ago

FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort

4 years ago

Is the clock ticking on Moderna's patent promise? Activists fear South African patents could hinder vaccine production

4 years ago

Avalo Therapeutics shuffles leadership team as the flailing biotech searches for a port in the storm

4 years ago

Covid-19 roundup: Pfizer, BioNTech's Omicron-specific shot delayed as surge wanes, while Moderna eyes August rollout

4 years ago

EMA might deny Merck's molnupiravir conditional marketing authorization — report

4 years ago

As patent debate swirls, BioNTech CEO promises not to enforce Covid vaccine IP rights in Africa — report

4 years ago

Moderna turns to Asia, plots new hires as it ponders $35B+ Covid-19 vaccine windfall

4 years ago

Covid-19 roundup: Despite treatment shortages, some US pharmacies report pile-ups of Merck's antiviral

4 years ago

First page Previous page 12 13 141516 17 18 Next page Last page